1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island

365

companies

as of March 31, 2024

Companies are divided into categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the minor field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

AIREX Inc.

Major field:Contract Research

Miner field:IT

Miner field:Cosmetic

Address: 【Odor Research Center】
〒650-0047  Room 408, Kobe Health Industry Development Center,   6-7-4 Minatojima Minami-cho, Chuo-ku, Kobe City, Hyogo Prefecture
【Headquarters/Technical Research Institute】
〒259-1292  6th floor, Tokai University Building 17, 4-1-1   Kitaganeme, Hiratsuka City, Kanagawa Prefecture
(Contact Person Koki Sohara)
TEL:
+81-0463-73-7025
FAX:
+81-0463-73-7034
Web site: https://airex-jpn.com/ E-mail: info@airex-jpn.com

MYTECH,Inc.

Major field:Diagnostic Agent and Device

Miner field:Genomics

Miner field:Outsourcing Business for Hospital

R&D, production and sale of biochips

Overview

The biochip technology of MYTEC can detect the substance of a very very small quantity molecular level in a short time. It was the first in the world to success is effective to adsorb specifically protein biochip surface "quantum crystal," "peroxide meso silver crystal" (3-dimensional self-assembled crystal) produced.
Simple, rapid, epigenetic analysis Proteo ® chip is the "new biochip".

Product / Service / PR

    Products: Proteo ® chip
    ・Detection from Stage 0 (very early diagnosis)
    ・Measurement time is the world's fastest (Detected within 10 minutes)
    ・Identification of cancer types
    Identification of cancer types and screening of cancer presence or absence can be checked at the same time from the blood of 1μl slightly.
Address: HI-DEC Kobe 101, 6-7-4 Minatojimaminamimachi,Kobe Chuo-ku, Hyogo 650-0047 JAPAN  (Contact Person Hasegawa Yuki)
TEL: +81-79-228-2806
Web site: http://www.sers-mytech.com/index.php E-mail: mytech@maia.eonet.ne.jp

Oncolys BioPharma Inc.

Major field:Drug Discovery

Miner field:Production of Drugs and Quasi Drugs

Miner field:Diagnostic Agent and Device

R&D of medicine

Overview

Unique drug discovery and development standing on virology.
We do our business activities of pharmaceutical and diagnostic businesses together under the concept of "drug discovery and development standing on virology".
In pharmaceutical business, we will develop safe, effective and novel drug targeting "cancer and serious infectious diseases" that can be a new option of therapy for such intractable diseases. In diagnostic business, we will provide new inspection services using genetic modification technology for virus that is our platform technology. We will establish multiple earning structures based on the achievement by the activities above, and accelerate the development of current new drug candidates under more stable management environment. In addition, we will actively seek or obtain seeds for new drugs to continue and expand our business for the future.

Product / Service / PR

    TelomeScan is a gene-modified virus for detecting cancer cell. The insertion into the virus of a green fluorescent protein (GFP) gene from jellyfish causes cancer cells to emit green fluorescent light as the virus replicates within them, enabling sensitive detection of circulating tumor cells (CTC) which detach from the tumor and circulate within the blood. We focus on especially the detection of CTCs in lung cancer that was difficult to efficiently detect using the conventional technologies and the detection of CTCs on prostate cancer and breast cancer. In these areas, increase in the number of patients is predicted. Oncolys BioPharma provides services not only reporting the number of CTCs in blood but also analyzing the grade of malignancy (T-CAS: TelomeScan CTC Analysis System), and it is expected that such services allow prediction of prognosis and the selection of appropriate treatments of cancer patients. It is further expected that Telome Scan realizes gene analysis services using CTCs (T-GEN: TelomeScan Genotyping System) and facilitates the option to select anti-cancer drugs suitable for cancer patients without conducting risky tissue biopsy for cancers.
Address: 4-1-28 Toranomon, Minato-ku, Tokyo, 105-0001, JAPAN  (Contact Person Corporate Planning Department)
TEL: +81-3-5472-1578 FAX: +81-3-5472-1488
Web site: https://www.oncolys.com E-mail: oncolys_information@oncolys.com

Organization for Small & Medium Enterprises and Regional Innovation, JAPAN

Major field:Assisting Businesses, Rental Laboratories and Offices

Operating Kobe Medical Device Development Center, Kobe Healthcare Industry Development center, etc.

Qualavance, Inc.

Major field:Drug Discovery